Management and Prevention of Nausea and Vomiting Supportive Care


Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting (July 12, 2016)

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting.... Continue Reading

Arrhythmia Risk Leads to Label Change for Zofran (July 9, 2012)

Interim data from a recent clinical trial has indicated that a 32 mg single dose of Zofran® (ondansetron) may affect the electrical activity of the heart and could predispose patients to develop an abnormal... Continue Reading

Study Suggests Long-acting Patch that Prevents Nausea and Vomiting Can Be Given in Combination with Intravenous Medication (February 9, 2010)

Use of a combination of Sancuso® (granisetron transdermal system; a patch that delivers granisetron through the skin for up to five days) and intravenous granisetron appears to be safe and feasible. This... Continue Reading

Sancuso® Transdermal Patch for Management of Chemotherapy-induced Nausea and Vomiting (September 23, 2008)

In September 2008 the United States Food and Drug Administration (FDA) approved Sancuso® (Granisetron Transdermal System) for the treatment of chemotherapy-induced nausea and vomiting (CINV). Sancuso... Continue Reading

Sancuso® Approved for Chemotherapy-induced Nausea and Vomiting (September 15, 2008)

Sancuso® Approved for Chemotherapy-induced Nausea and Vomiting The United States Food and Drug Administration (FDA) has approved Sancuso® (Granisetron Transdermal System) for the treatment of chemotherapy-induced... Continue Reading

More than Half of Oncology Nurses Stop or Delay Chemotherapy Due to Nausea and Vomiting (June 24, 2008)

More than Half of Oncology Nurses Stop or Delay Chemotherapy Due to Nausea and Vomiting More than half of oncology nurses will completely stop or delay their patients’ chemotherapy regimens due to... Continue Reading

Some Chinese Herbs Reduce Nausea Associated with Chemotherapy (April 3, 2007)

Some Chinese Herbs Reduce Nausea Associated with Chemotherapy According to an article recently published in the Annals of Oncology, treatment with Chinese herbal medicine (CHM), as prescribed by a Chinese... Continue Reading

Addition of Dexamethasone to Zofran® Provides Modest Improvement in Radiation-induced Vomiting (August 15, 2006)

Addition of Dexamethasone to Zofran® Provides Modest Improvement in Radiation-induced Vomiting Among patients undergoing radiation therapy to the upper abdomen, preventive treatment with dexamethasone... Continue Reading

Cesamet™ Approved for Nausea and Vomiting Associated with Cancer Treatment (May 19, 2006)

The U.S. Food and Drug Administration (FDA) has recently approved the agent Cesamet™ (nabilone) for the treatment of nausea and vomiting in cancer patients undergoing therapy who have not responded to... Continue Reading

Nausea and Vomiting Significant Among Very Young Pediatric Patients Undergoing Chemotherapy (February 17, 2006)

Nausea and Vomiting Significant Among Very Young Pediatric Patients Undergoing Chemotherapy According to a recent article published in the journal Cancer, nausea and vomiting are still significant side... Continue Reading

Emend® Approved for Prevention of Moderate Chemotherapy-Associated Nausea and Vomiting (January 12, 2006)

The Food and Drug Administration (FDA) recently added another indication to the antinausea drug (antiemetic) Emend® (aprepitant) for patients with cancer undergoing chemotherapy. The new indication includes... Continue Reading

Acupuncture May Prevent Some Cases of Chemotherapy-Induced Nausea and Vomiting (October 3, 2005)

Acupuncture May Prevent Some Cases of Chemotherapy-Induced Nausea and Vomiting According to a review published in the Journal of Clinical Oncology, certain types of acupuncture-point stimulation may relieve... Continue Reading

Delayed Nausea After Chemotherapy Poses Treatment Challenge (September 20, 2005)

Neither prochlorperazine nor first-generation 5-HT-receptor antagonists offer sufficient control of delayed chemotherapy-induced nausea, according to a study published in The Lancet Oncology. Chemotherapy... Continue Reading

Emend® Reduces Chemotherapy-Induced Nausea and Vomiting (August 30, 2005)

Emend® Reduces Chemotherapy-Induced Nausea and Vomiting Among cancer patients receiving more than one nausea-inducing chemotherapy drug, the addition of the antiemesis drug Emend® (aprepitant) to standard... Continue Reading

Aloxi™ Remains Superior in Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting (July 1, 2004)

Aloxi™ Remains Superior in Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting According to the 40th annual meeting of the American Society of Clinical Oncology (ASCO), Aloxi™ (palonosetron)... Continue Reading

Aloxi™ plus Emend® Highly Effective in Preventing Chemotherapy-Induced Nausea and Vomiting (June 17, 2004)

According to results presented at the 40th annual meeting of the American Society of Clinical Oncology (ASCO), the combination of the anti-emetics Aloxi™ (palonosetron) plus Emend® (aprepitant) is highly... Continue Reading

Chemotherapy-Induced Nausea and Vomiting Greatly Underestimated by Healthcare Providers (May 27, 2004)

Chemotherapy-Induced Nausea and Vomiting Greatly Underestimated by Healthcare Providers According to a recent article published in the journal Cancer, healthcare providers greatly underestimate the incidence... Continue Reading

Aloxi™ Incorporated into 2004 NCCN Guidelines (May 7, 2004)

Aloxi™ Incorporated into 2004 NCCN Guidelines The antiemetic agent Aloxi™ (palonosetron hydrochloride) has recently been incorporated into the 2004 National Comprehensive Cancer Network® (NCCN®)... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS